Research & Innovation
We plan to change
the future of healthcare
It is the right time to take action.
Right now, somewhere, a pharmaceutical company is drowning in clinical study data that could save your mother. An insurance algorithm is deciding your family member isn't worth the experimental treatment. A breakthrough sits in a lab in Lithuania that could help patients somewhere else, but it takes years before it is allowed on the market.
Why? Because valuable research is locked away. Not due to lack of willingness, but because regulation has built a wall around data sharing. We don't have a knowledge problem. We have an over-regulation problem.
We Dared
CW1 stands for fair healthcare and doesn't do research to publish buried papers. We do it to make change and see it happen.
We patented our own 8-layered AES encryption with a 512-bit tripartite key algorithm, which benchmarks at 3.2 bpv against the tokenization algorithms used by payment processors and allows us to fully anonymize data.
We welcome healthcare providers, pharmaceuticals, medical device manufacturers, insurers, and others to join our partner network, which makes regulatory collaboration easy in favor of research.
We monitor the vitals of different patients who participate in studies and gladly want to contribute to being understood by their providers (our partners).
We developed an affordable healthcare insurance model that allows patients more affordable insurance while increasing revenues for insurers, based on the concept of swapping bonds.
Explore
CW1 Latest Findings
Leading Team in Different Areas
Medical
Dr. M. Bonk, MD
Dr. Maximilian oversees all CW1 medical research. A renowned neurosurgeon and robotics expert, he is also the Head of Alma Mater Vienna and Dean of the Department of Physiotherapy.
Finance
Dr. P. Stark, PhD
Pedro founded the CW1 Group in 2019 and sits as managing partner. He previously worked at one of the Big-4 firms and in different European initiatives in the healthcare insurance sector.
Discover
Our Methodology
CW1 observes, documents, analyzes, processes, and produces conclusions. We are fortunate to gather extremely qualified in-house expertise in Medicine, Strategy & Financial Consulting, and Technology, which creates a unique combination of researchers.
Apart from clinical trials in partnership with a great network of partners, we have launched Lisbon BioResearchCenter, which intends to develop proprietary algorithms for early-stage disease detection through the monitoring of daily activities.
Read more about Lisbon BioResearchCenter>Leveraging our
Partner Ecosystem
CW1 is committed to building a strong and trusted ecosystem of partners made up of doctors, hospitals, insurance companies, government bodies, and patients.
Currently conducting research within 5 different countries.
Research project
Patient mobility & optimization of rural healthcare provision.
Research & advisory
Hospital efficiency and workflow optimization & financial sustainability.
Continuous research
On cardiological disease diagnosis through measurement of HRV.
Improve & Optimize
Current Research Projects
Portugal & Sweden
Impact of patient preferences in dental clinics
Study on how patient preferences impact the patient retention rate among different areas in Europe
Germany, Portugal & Sweden
Pediatric coverage for secondary service provision.
Study on the efficiency optimization of decoupled medical workflows.
Germany & Portugal
Hospital efficiency
Study on the efficiency optimization of decoupled medical workflows.
We use cookies to give you the best possible experience, and while some are essential, others help us understand how you use the site, so we can improve it. Click “Accept all cookies” to proceed as specified, “Decline optional cookies” to accept only essential cookies, or click “Manage my preferences” to choose what cookie types you will accept. Cookie Policy.
